ArticleInvestigational new drugs2025

An investigation of extended-interval dosing of atezolizumab in Japanese patients with advanced solid tumors: safety and pharmacokinetics of a dose of 1680 mg every 4 weeks.

Shunsuke Kondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.